The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
A Lancaster University research team has been boosted by a £100,000 investment. LYVA Labs has invested £100,000 into ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
4don MSNOpinion
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
4hon MSN
DALLAS (AP) — A New York doctor's alleged decision to send abortion pills to patients in Texas and Louisiana has pitted the ...
4d
GlobalData on MSNSuper Bowl ad for copycat weight loss drugs stokes pharma power debateControversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
10hon MSN
ROME (AP) — Pope Francis was hospitalized Friday after a weeklong bout of bronchitis worsened and was receiving drug therapy ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
4d
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results